Suchergebnisse - "Eikelboom, John W"

PubPharm (825)

91

Letter to the editor : Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns

enthalten in: European heart journal. Cardiovascular pharmacotherapy | 2021

von Fiolet, A. | Opstal, T. | Mosterd, A. | +6

CommentOn: Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e18-e19. - PMID 33270128

92

Efficacy and safety of low-dose colchicine in patients with coronary disease : a systematic review and meta-analysis of randomized trials

enthalten in: European heart journal | 2021

von Fiolet, A. | Opstal, T. | Mosterd, A. | +11

CommentIn: Eur Heart J. 2021 Jul 21;42(28):2776-2779. - PMID 33824963

93

Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease

enthalten in: Heart (British Cardiac Society) | 2021

von Dagenais, G. | Dyal, L. | Bosch, J. | +12

94

Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease

enthalten in: Journal of the American College of Cardiology | 2021

von Eikelboom, J. | Bhatt, D. | Fox, K. | +15

CommentIn: J Am Coll Cardiol. 2021 Jul 6;78(1):24-26. - PMID 34210410

95

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

enthalten in: bioRxiv.org | 2021

von Talasaz, A. | Sadeghipour, P. | Kakavand, H. | +24

96

What is the role of growth-differentiation factor-15 in biomarker-based prediction of mortality in patients with atrial fibrillation?

enthalten in: European journal of internal medicine | 2021

von Benz, A. | Eikelboom, J.

CommentOn: Eur J Intern Med. 2021 Jun;88:35-42. - PMID 33706979

97

Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial)

enthalten in: The American journal of cardiology | 2021

von Millenaar, D. | Schumacher, H. | Brueckmann, M. | +9

98

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage : ANNEXA-4 Substudy

enthalten in: Stroke | 2021

von Demchuk, A. | Yue, P. | Zotova, E. | +14

CommentIn: Stroke. 2021 Jun;52(6):2106-2108. - PMID 33966496

99

Reply : All Fat Is Not Created Equal: The Problem of Defining Obesity in the Elderly

enthalten in: Journal of the American College of Cardiology | 2021

von Guzik, T. | Eikelboom, J.

CommentOn: J Am Coll Cardiol. 2021 Feb 9;77(5):511-525. - PMID 33538248

100

Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation

enthalten in: Circulation | 2021

von Benz, A. | Hijazi, Z. | Lindbäck, J. | +5